Media Coverage
 

FDA OKs Breakthrough Cholesterol Drug for High-Risk Patients
The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.An estimated 6.3 million U.S. patients cannot control their LDL levels with statins alone, according to medical surveys. And another 3.3 million are thought to be unable to tolerate statins due to side effects, but there are no formal criteria to identify these patients. As such, experts say more research is needed to define the group. "I think we need to be clear what qualifies for statin intolerance," Dr. Neil Stone, a cardiologist at Northwestern University, said. "What moves you from an inexpensive, generic statin to a very expensive new drug that doesn't have near the track record of the statin?"
The New York Times Jul 27, 2015
Best Hospitals 2015-16: an Overview
In Chicago, a third crowded market, Northwestern Memorial Hospital ranked first in the metro area.
U.S. New & World Report Jul 22, 2015
Becoming a dad? Expect to gain 3 to 5 pounds, study suggests
The study's lead author — Dr. Craig Garfield of Northwestern University — said he could only speculate about what's behind the extra pounds. "For men who become fathers, their whole life changes," Garfield said. They may sleep less, exercise less, and experience more stress — all of which can lead to weight gain, he said.
Associated Press Jul 22, 2015
2 Studies Back Guidelines for Wider Use of Statins
Two studies published Tuesday lend support to controversial new cholesterol guidelines that could vastly increase the number of Americans advised to take cholesterol-lowering drugs called statins.
The New York Times Jul 15, 2015
Faculty Teaching Opportunities Interested in leading small group discussions and teaching and assessing medical student clinical skills? See a list of opportunities.

Submit your nomination for the $200,000 Mechthild Esser Nemmers Prize in Medical Science, open to physician-scientists whose body of research exhibits outstanding achievement and lasting significance.